#Israel #Ramat Gan #NGD Infection Prevention #Sheba Medical Center #NGD200 System

NGD Infection Prevention and Sheba Medical Center's New Alliance

NGD Infection Prevention, known for its innovative approach to real-time genomic transmission detection in hospitals, has marked a significant milestone by deploying its integrated transmission detection system at the prestigious Sheba Medical Center located in Ramat Gan, Israel. As the largest medical facility in the Middle East and consistently ranked among the world's top ten hospitals, Sheba is now the first hospital in Israel to adopt NGD's advanced sequencing-based system designed to detect and prevent infectious outbreaks as they begin.

Enhancement of Infection Control

Through a statement from NGD's Director of Strategic Partnerships, it was emphasized that Sheba Medical Center is recognized for being an early adopter of effective technologies, aligning perfectly with NGD's ambitions. The director stated, "They acknowledge the unique capacity of bacterial sequencing for immediate transmission identification and appreciate our solution's cost-effectiveness and ease of use suitable for high-volume operations like Sheba."

The implementation of this system is crucial as the region faces significant challenges with drug-resistant bacterial infections. Paul A. Rhodes, Ph.D., NGD’s CEO, reminded us that early identification of outbreaks could lead to timely interventions and reduced transmission risks. He shared insights from a retrospective demonstration where sequencing uncovered the full picture of transmission at Sheba, revealing the necessity for such technology to empower healthcare teams in the fight against infections.

A Groundbreaking Technology

The NGD200 system combines low-cost, fully automated sequencing sample preparation with comprehensive bioinformatic analysis and actionable reporting. By creating an end-to-end approach, the technology enables hospitals like Sheba to efficiently manage infection control. This automatic process ensures timely response capabilities for healthcare providers, alongside reducing overall patient care costs and length-of-stay through effective infection management.

Features of the NGD200 system include:

• - Automated Sample Preparation: Minimizing human error and time spent on the sample prep phase, streamlining efficiency.
• - Automated Bioinformatic Analysis: Providing instantaneous insights into outbreak metrics and the underlying causes of infection spread.
• - User-Friendly Interface: The EpiAssist interface delivers daily reports, equipping healthcare teams with necessary insights for proactive management of infection control.

This state-of-the-art system exemplifies a shift in healthcare technology, emphasizing the critical importance of real-time data in patient treatment scenarios.

Looking at the Future

As NGD continues to deploy its technology throughout the region, it paves the way for not just enhanced infection prevention in Sheba but potentially across the Middle East where the need is significant. Dr. Rhodes expressed confidence that other prominent medical centers in Israel would quickly recognize the potential benefits of implementation, paralleling the urgency seen at Sheba.

NGD Infection Prevention aims to bring about a lasting change in infection control, with further deployments anticipated amidst the pressing need for reliable and effective healthcare solutions.

With this crucial partnership, Sheba Medical Center has taken a significant step forward, and the implications of this technology might very well set new standards for medical practices in the region and beyond.

In conclusion, the NGD200 system represents a pivotal advancement in infection control technology, showcasing the power of rapid sequencing in healthcare, empowering teams to engage proactively in managing transmission risks effectively and protecting patient health.